Kirkwood JM - Search Results

1

Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study.

Chesney J, Lewis KD, Kluger H, Hamid O, Whitman E, Thomas S, Wermke M, Cusnir M, Domingo-Musibay E, Phan GQ, Kirkwood JM, Hassel JC, Orloff M, Larkin J, Weber J, Furness AJS, Khushalani NI, Medina T, Egger ME, Graf Finckenstein F, Jagasia M, Hari P, Sulur G, Shi W, Wu X, Sarnaik A. Chesney J, et al. Among authors: kirkwood jm. J Immunother Cancer. 2022 Dec;10(12):e005755. doi: 10.1136/jitc-2022-005755. J Immunother Cancer. 2022. PMID: 36600653 Free PMC article. Clinical Trial.

2

Studies of interferons in the therapy of melanoma.

Kirkwood JM. Kirkwood JM. Semin Oncol. 1991 Oct;18(5 Suppl 7):83-90. Semin Oncol. 1991. PMID: 1948134 Review.

3

Human IgG and IgM monoclonal antibodies against autologous melanoma produced by Epstein-Barr-virus-transformed B lymphocytes.

Kirkwood JM, Robinson JE. Kirkwood JM, et al. Cancer Immunol Immunother. 1990;32(4):228-34. doi: 10.1007/BF01741705. Cancer Immunol Immunother. 1990. PMID: 2175672 Free PMC article.

4

Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.

Weidmann E, Logan TF, Yasumura S, Kirkwood JM, Trucco M, Whiteside TL. Weidmann E, et al. Among authors: kirkwood jm. Cancer Res. 1993 Oct 15;53(20):4745-9. Cancer Res. 1993. PMID: 8402652

5

Immunomodulatory function of interferon-gamma in patients with metastatic melanoma: results of a phase II-B trial in subjects with metastatic melanoma, ECOG study E 4987. Eastern Cooperative Oncology Group.

Kirkwood JM, Bryant J, Schiller JH, Oken MM, Borden EC, Whiteside TL. Kirkwood JM, et al. J Immunother. 1997 Mar;20(2):146-57. doi: 10.1097/00002371-199703000-00007. J Immunother. 1997. PMID: 9087387 Clinical Trial.

6

Efficacy, safety, and risk-benefit analysis of adjuvant interferon alfa-2b in melanoma.

Kirkwood JM, Resnick GD, Cole BF. Kirkwood JM, et al. Semin Oncol. 1997 Feb;24(1 Suppl 4):S16-23. Semin Oncol. 1997. PMID: 9122729

7

Hyperthermic isolated limb perfusion with tumor necrosis factor alone for melanoma.

Posner MC, Lienard D, Lejeune FJ, Rosenfelder D, Kirkwood J. Posner MC, et al. Cancer J Sci Am. 1995 Nov-Dec;1(4):274-80. Cancer J Sci Am. 1995. PMID: 9166488

8

Phase IB trial of picibanil (OK-432) as an immunomodulator in patients with resected high-risk melanoma.

Kirkwood JM, Wilson J, Whiteside TL, Donnelly S, Herberman RB. Kirkwood JM, et al. Cancer Immunol Immunother. 1997 May;44(3):137-49. doi: 10.1007/s002620050366. Cancer Immunol Immunother. 1997. PMID: 9191873 Free PMC article. Clinical Trial.

9

Adjuvant therapy of melanoma.

Agarwala SS, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Semin Surg Oncol. 1998 Jun;14(4):302-10. doi: 10.1002/(sici)1098-2388(199806)14:4<302::aid-ssu6>3.0.co;2-6. Semin Surg Oncol. 1998. PMID: 9588723 Review.

10

A phase III randomized trial of dacarbazine and carboplatin with and without tamoxifen in the treatment of patients with metastatic melanoma.

Agarwala SS, Ferri W, Gooding W, Kirkwood JM. Agarwala SS, et al. Among authors: kirkwood jm. Cancer. 1999 May 1;85(9):1979-84. Cancer. 1999. PMID: 10223239 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

578 results

Search Page